Rasagiline Rescue in Alzheimer's Disease Clinical Trial
Status:
Completed
Trial end date:
2019-01-04
Target enrollment:
Participant gender:
Summary
This is a Phase II, randomized, double blind, placebo controlled, parallel group, proof of
concept three-site study, to evaluate the effect of Rasagiline in the regional brain
metabolism on 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose (FDG-PET).